Medicovestor

Company

Medicovestor develops one asset, in phase 1 (MC001 in pancreatic cancer). Mostly antibody.

1
Asset
Furthest stage
Phase 1
0
Trials
0
Signals

Pipeline

1
  • MC001

    Antibody-drug conjugate targeting pancreatic cancer

    Phase 1, Antibody, pancreatic cancer

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Similar companies5

Intelligence